Lymphoma & Plasma Cell Disorders
Case Reports
An unusual case of primary cardiac prosthetic valve-associated lymphoma
New Therapies
Meeting the potential of immunotherapy: new targets provide rational combinations
Case Reports
Durable response to pralatrexate for aggressive PTCL subtypes
The JCSO Interview
New myeloma drugs improve response and extend survival
New Therapies
Immunotherapies shape the treatment landscape for hematologic malignancies
News
Study links communication, outcomes in cancer
Better communication between cancer patients and healthcare providers may provide tangible benefits, according to research published in JNCCN....
News
Mogamulizumab prolongs PFS in CTCL
Mogamulizumab is an effective treatment option for relapsed/refractory cutaneous T-cell lymphoma (CTCL), according to researchers. In the phase 3...
News
Auto-HSCT linked to higher AML, MDS risk
Patients undergoing autologous hematopoietic stem cell transplant (auto-HSCT) for lymphoma or myeloma have an increased risk of acute myeloid...
News
Group releases new CLL guidelines
Fludarabine, cyclophosphamide, and rituximab are recommended as initial therapy for fit patients with chronic lymphocytic leukemia (CLL) who do...
News
Insurance status linked to survival in FL patients
Having health insurance can mean the difference between life and death for US patients with follicular lymphoma (FL), according to research...
From the Journals
Groups release guidelines for CAR T treatment in children
Some of the tools used to detect toxicity that are used in older patients don’t work well in children.